ABSTRACT
Steroid hormones, such as progesterone, are able to modify immunity and influence disease outcome. Dendritic cells (DCs) drive potent immune responses, express receptors for steroid hormones, and may be a primary target of steroid hormone actions during infection of the genital tract, including uterine tissue. Here, we report that progesterone limited DC-associated activation marker expression and inhibited cytokine secretion by uterine DCs, which was associated with changes in signal transducer and activator of transcription 1 (STAT1) activity. We also found that DCs from mice at stages with higher progesterone concentrations (diestrus, metaestrus) were more sensitive to progesterone than those in stages with lower progesterone concentrations (proestrus, estrus), both in vitro and in vivo. This difference correlated with the levels of progesterone receptor expressed by DCs. These data suggest that progesterone regulates DC function and could contribute to the susceptibility of females to uterine and other genital tract infections at selected time periods throughout the life cycle.
Subject(s)
Cytokines/biosynthesis , Dendritic Cells/metabolism , Progesterone/metabolism , Receptors, Progesterone/biosynthesis , STAT1 Transcription Factor/metabolism , Administration, Intravaginal , Animals , Cell Differentiation/physiology , Cells, Cultured , Cytokines/genetics , Cytokines/immunology , Cytokines/metabolism , Dendritic Cells/cytology , Dendritic Cells/immunology , Female , Lipopolysaccharides/immunology , Lipopolysaccharides/metabolism , Menstrual Cycle/blood , Mice , Mice, Inbred C57BL , Progesterone/blood , Progesterone/immunology , Receptors, Progesterone/genetics , Receptors, Progesterone/immunology , STAT1 Transcription Factor/genetics , STAT1 Transcription Factor/immunology , Signal Transduction/physiology , Transcriptional Activation/physiology , Uterus/cytologyABSTRACT
It is hypothesized that oxidative reactions of hemoglobin driven by reactive oxygen species in the vasculature lead to endothelial cell injury or death. Bovine aortic endothelial cells were incubated with diaspirin cross-linked hemoglobin (DBBF-Hb), developed as a hemoglobin-based oxygen carrier, and hydrogen peroxide (H(2)O(2)), generated by the glucose oxidase system. The low steady flux of H(2)O(2) oxidizes the ferrous form of DBBF-Hb and drives the redox cycling of ferric and ferryl DBBF-Hb. Cells underwent rounding, swelling and detachment, and accumulated in the G2/M phase of the cell cycle. G2/M arrest preceded the onset of apoptosis as determined by increases in phosphatidylserine (PS) externalization and sub-G1 events. Redox cycling of unmodified hemoglobin also led to G2/M arrest and apoptosis. The rate and extent of DBBF-Hb oxidation correlated with the onset and extent of G2/M arrest and apoptosis and induced significant decreases in soluble reduced thiols. Earlier depletion of glutathione by pretreatment with buthionine sulfoximine rendered cells more susceptible to G2/M arrest and apoptosis. The caspase inhibitor, z-VAD-fmk, had no effect on the induction of G2/M arrest but completely inhibited the subsequent increases in PS externalization and sub-G1 events. Catalase inhibited DBBF-Hb oxidation, the loss of thiols, and the onset of G2/M arrest and apoptosis. These data support a causative role for the ferric-ferryl redox cycle in the development of endothelial cell injury.
Subject(s)
Apoptosis , Aspirin/analogs & derivatives , Aspirin/metabolism , Endothelium, Vascular/cytology , G2 Phase , Hemoglobins/metabolism , Mitosis , Animals , Aorta , Apoptosis/drug effects , Buthionine Sulfoximine/pharmacology , Caspase Inhibitors , Catalase/pharmacology , Cattle , Cells, Cultured , Endothelium, Vascular/metabolism , Enzyme Inhibitors/pharmacology , Ferric Compounds/metabolism , Ferrous Compounds/metabolism , Glucose Oxidase/metabolism , Glutathione/metabolism , Hemoglobins/chemistry , Hydrogen Peroxide/metabolism , Microscopy, Phase-Contrast , Oxidation-Reduction , Phosphatidylserines/metabolism , Sulfhydryl Compounds/metabolismABSTRACT
We investigated cellular injury and death induced by ultrapure human Hb (HbA(0)) and its diaspirin cross-linked derivative DBBF-Hb in normal and glutathione (GSH)-depleted bovine aortic endothelial cells subjected to hydrogen peroxide (H(2)O(2)). HbA(0) underwent extensive degradation and heme loss, whereas DBBF-Hb persisted longer in its ferryl (Fe(4+)) form. The formation of ferryl HbA(0) or ferryl DBBF-Hb was associated with a significant decrease in endothelial cell GSH compared with the addition of H(2)O(2) or Hbs alone. This effect was inhibited by catalase, but not by superoxide dismutase or deferoxamine mesylate. The presence of HbA(0) and DBBF-Hb reduced H(2)O(2)-induced apoptosis, as measured by cell morphology, annexin V binding assay, and caspase inhibition, consistent with the ability to consume H(2)O(2) in an enzyme-like fashion. However, the pattern of cell death and injury produced by HbA(0) and DBBF-Hb appeared to be distinctly different among proteins as well as among cells with and without GSH. These findings may have important implications for the use of cell-free Hb as oxygen therapeutics in patients with coexisting pathologies who may lack antioxidant protective mechanisms.
Subject(s)
Aspirin/analogs & derivatives , Endothelium, Vascular/physiology , Hemoglobin A/pharmacology , Hydrogen Peroxide/pharmacology , Oxidants/pharmacology , Sulfhydryl Compounds/metabolism , Animals , Annexin A5/metabolism , Aorta/cytology , Aorta/drug effects , Aorta/metabolism , Aorta/physiology , Apoptosis/drug effects , Aspirin/pharmacology , Cattle , Cell Death/drug effects , Cells, Cultured , Endothelium, Vascular/cytology , Endothelium, Vascular/drug effects , Endothelium, Vascular/metabolism , Glutathione/metabolism , Heme/metabolism , Hemoglobins/pharmacology , HumansABSTRACT
Safe and effective hemoglobin-based blood substitutes may be advantageous over conventional therapies for certain clinical settings requiring short term blood replacement such as emergency resuscitation and hemodilution in surgery. Many advances have been made in developing these oxygen therapeutics, however safety concerns continue to slow their clinical progress. An important and often overlooked consideration in evaluating the safety of modified hemoglobins is the impact of chemical and/or genetic modifications on the redox chemistry of these proteins. Diaspirin cross-linked hemoglobin (DBBF-Hb) has been extensively evaluated in vitro and in animal models, and thus represents a useful model to explore possible correlations between structural-functional alterations and toxicity of hemoglobin-based blood substitutes.
Subject(s)
Aspirin/analogs & derivatives , Blood Substitutes/chemistry , Blood Substitutes/toxicity , Hemoglobins/chemistry , Hemoglobins/toxicity , Animals , Aspirin/chemistry , Aspirin/toxicity , Humans , Oxidation-ReductionABSTRACT
This paper discusses our research on two new generation blood substitutes. One is based on the crosslinking of hemoglobin, superoxide dismutase(SOD) and catalase (CAT) to form polyhemoglobin-SOD-CAT. This is being investigated for use in conditions with potential problems related to ischemia-reperfusion injuries as in severe hemorrhagic shock, stroke and other conditions. The second one is based on biodegradable polymeric nanocapsules containing hemoglobin and enzymes. In this form, the hemoglobin and enzymes are separated from the external environment. Furthermore, modifications of the polymeric membrane can result in increase in circulation time.
Subject(s)
Blood Substitutes/pharmacology , Catalase/pharmacology , Hemoglobins/pharmacology , Superoxide Dismutase/pharmacology , Animals , Blood Substitutes/administration & dosage , Blood Substitutes/chemistry , Catalase/administration & dosage , Catalase/chemistry , Hemoglobins/administration & dosage , Hemoglobins/chemistry , Humans , Microspheres , Polymers , Reperfusion Injury/drug therapy , Superoxide Dismutase/administration & dosage , Superoxide Dismutase/chemistrySubject(s)
Apoptosis/drug effects , Endothelium, Vascular/drug effects , Oxyhemoglobins/pharmacology , Animals , Blood Substitutes/isolation & purification , Blood Substitutes/pharmacology , Blotting, Western , Cattle , Cells, Cultured , Chromatography, Ion Exchange , Drug Contamination , Endothelium, Vascular/cytology , Enzyme-Linked Immunosorbent Assay , Filtration , Free Radicals/pharmacology , Hemoglobins/isolation & purification , Hemoglobins/pharmacology , Hot Temperature , Humans , Isoelectric Focusing , Lipopolysaccharides/adverse effects , Oxyhemoglobins/isolation & purification , Reactive Oxygen SpeciesABSTRACT
We investigated the toxicity of hemoglobin/myoglobin on endothelial cells under oxidative stress conditions that include cellular hypoxia and reduced antioxidant capacity. Bovine aorta endothelial cells (BAECs), grown on microcarrier beads, were subjected to cycles of hypoxia and reoxygenation in a small volume of medium, and endothelial cell monolayers were depleted of their intracellular glutathione (GSH) by treatment with buthionine sulfoximine. Incubation of diaspirin cross-linked hemoglobin (DBBF-Hb) or horse skeletal myoglobin (Mb) with BAECs subjected to 3 h of hypoxia caused transient oxidation of the hemoproteins to the ferryl form (Fe(4+)). Formation of the ferryl intermediate was decreased in a concentration-dependent manner by the addition of L-arginine, a substrate of NO synthase, after 3 h of hypoxia. Optimal inhibition of ferryl formation, possibly due to the antioxidant action of NO, was achieved with 900 microM L-arginine. Addition of hydrogen peroxide to GSH-depleted cells in the presence of DBBF-Hb or Mb significantly decreased cell viability. Ferryl Mb, but not ferryl DBBF-Hb, was observed in samples analyzed at the end of treatment, which may explain the greater toxicity observed with Mb as opposed to DBBF-Hb. This model may be utilized to identify causative agent(s) associated with hemoprotein cytotoxicity and in designing strategies to suppress or control heme-mediated injury under physiologically relevant conditions.
Subject(s)
Cell Hypoxia , Endothelium, Vascular/metabolism , Glutathione/deficiency , Animals , Aspirin/analogs & derivatives , Aspirin/pharmacology , Cattle , Cell Survival , Cells, Cultured , Hemoglobin A/pharmacology , Hydrogen Peroxide/pharmacology , Lipid Peroxidation/drug effects , Myoglobin/pharmacology , Oxidative Stress , SpectrophotometryABSTRACT
Polyhemoglobin-superoxide dismutase-catalase is designed to function as an oxygen carrier with antioxidant properties. This is based on cross-linking hemoglobin with superoxide dismutase and catalase (PolyHb-SOD-CAT). This study describes the structural and antioxidant properties of this solution. Our studies show that superoxide dismutase and catalase retain their enzymatic activity following glutaraldehyde polymerization with 8:1 and 16:1 glutaraldehyde:hemoglobin ratio. We have analyzed the optimal SOD/CAT ratios to prevent oxidation of hemoglobin in the presence of oxygen free radicals. The circulation half-life of crosslinked hemoglobin, SOD, and catalase in Sprague-Dawley rats correlates with the degree of polymerization as determined by high-performance molecular weight gel filtration. PolyHb-SOD-CAT decreases the formation of oxygen radicals compared with PolyHb in a rat intestinal ischemia-reperfusion model.
Subject(s)
Blood Substitutes/therapeutic use , Catalase/therapeutic use , Hemoglobins/therapeutic use , Oxyhemoglobins/metabolism , Superoxide Dismutase/therapeutic use , Animals , Blood Substitutes/chemistry , Catalase/chemistry , Catalase/pharmacokinetics , Chromatography, Gel , Half-Life , Hemoglobins/chemistry , Hemoglobins/pharmacokinetics , Intestines/blood supply , Male , Molecular Weight , Protein Engineering , Rats , Rats, Sprague-Dawley , Reperfusion Injury/blood , Reperfusion Injury/drug therapy , Superoxide Dismutase/chemistry , Superoxide Dismutase/pharmacokinetics , Superoxides/chemistryABSTRACT
Crosslinking hemoglobin with superoxide dismutase and catalase (PolyHb-SOD-CAT) helps to limit free radical reactivity of modified hemoglobin red blood cell substitutes. In the present study, in vitro oxidant challenge experiments were performed with exogenous hydrogen peroxide (H2O2) and xanthine oxidase-derived superoxide (O2.-). PolyHb-SOD-CAT was compared to PolyHb for the presence of secondary hemoprotein-free radical events. PolyHb-SOD-CAT prevents ferrylhemoglobin formation, measured as Na2S-induced absorbance at 620 nm. Similarly, PolyHb-SOD-CAT inhibited ferrozine-detectable iron release at high oxidant-heme ratios. The formation of oxygen radicals, monitored by salicylate hydroxylation, was prevented at high oxidant-heme ratios with PolyHb-SOD-CAT. The peroxidation of liposomal membranes was also inhibited in PolyHb-SOD-CAT mixtures subject to oxidant challenge. These results show that PolyHb-SOD-CAT prevents secondary hemoprotein-associated free radical events. This new type of modified hemoglobin oxygen carrier with antioxidant activity may reduce the potential toxicity of hemoglobin-based substitutes in certain applications, especially during reperfusion of ischemic tissues.
Subject(s)
Catalase/drug effects , Hemoglobins/drug effects , Hemoglobins/metabolism , Superoxide Dismutase/drug effects , Animals , Blood Substitutes , Catalase/chemical synthesis , Catalase/chemistry , Cattle , Cross-Linking Reagents/chemistry , Ferrozine/metabolism , Free Radical Scavengers/antagonists & inhibitors , Free Radical Scavengers/metabolism , Glutaral/chemistry , Hemoglobins/chemical synthesis , Hemoglobins/chemistry , Hydrogen Peroxide/pharmacology , Hydroxylation , Iron/analysis , Iron/metabolism , Lipid Peroxidation/drug effects , Liposomes/chemistry , Models, Biological , Oxidation-Reduction/drug effects , Phospholipids/chemistry , Salicylic Acid/analysis , Salicylic Acid/metabolism , Superoxide Dismutase/chemical synthesis , Superoxide Dismutase/chemistry , Superoxides/chemical synthesis , Superoxides/pharmacology , Xanthine Oxidase/chemistryABSTRACT
The effects of PolyHb (intermolecularly crosslinked hemoglobin) and PolyHb-SOD-CAT (intermolecularly crosslinked hemoglobin, superoxide dismutase and catalase) on the production of hydroxyl radical was studied using a rat hindlimb model of ischemia-reperfusion. Hydroxyl radical generation was assessed by an indirect assay based on the hydroxylation of 4-hydroxybenzoate. The hydroxylation product, 3,4 dihydroxybenzoate (3,4 DHBA), was analyzed by high performance liquid chromatography and electrochemical detection. The identification of 3,4 DHBA was confirmed by analysis of authentic standard and an in vitro hydroxyl radical generation system. Ischemia was induced in both hindlimbs by ligation of the infrarenal aorta. After a 4hr ischemic period, hindlimbs were simultaneously perfused with PolyHb-SOD-CAT (5 g/dl) into one limb and PolyHb (5 g/dl) into the other limb via femoral arterial catheters. Each perfusate also contained the hydroxyl radical trap, 4-hydroxbenzoate (5 mM). Femoral venous effluents were analyzed for the presence of the 3,4 DHBA. Data indicates that greater 3,4 DHBA production occurs during PolyHb perfusion as compared to PolyHb-SOD-CAT. These preliminary results show that perfusion with PolyHb-SOD-CAT may alleviate oxidative stress in a model of ischemia-reperfusion.
Subject(s)
Catalase/pharmacology , Hemoglobins/pharmacology , Hydroxyl Radical/metabolism , Reperfusion Injury/drug therapy , Superoxide Dismutase/pharmacology , Animals , Anticarcinogenic Agents/analysis , Anticarcinogenic Agents/metabolism , Blood Substitutes/chemistry , Blood Substitutes/pharmacology , Catalase/chemistry , Cattle , Cross-Linking Reagents/chemistry , Cross-Linking Reagents/pharmacology , Disease Models, Animal , Hemoglobins/chemistry , Hindlimb , Hydroxybenzoates/analysis , Hydroxybenzoates/metabolism , Male , Muscle, Skeletal/blood supply , Muscle, Skeletal/drug effects , Muscle, Skeletal/metabolism , Parabens/analysis , Parabens/metabolism , Perfusion , Rats , Rats, Sprague-Dawley , Reperfusion Injury/metabolism , Superoxide Dismutase/chemistryABSTRACT
An in vivo rat model of isolated intestinal ischemia-perfusion was developed. This is used to compare the effects of crosslinked hemoglobin (PolyHb) versus crosslinked hemolobin-superoxide dismutase-catalase (PolyHb-SOD-CAT) on free radical generation in ischemia-reperfusion. Fasted, anesthetized male Sprague Dawley rats underwent midline laparotomy with cannulation of the abdominal aorta and inferior vena cava. Ligation was carried out at the renal pedicles bilaterally and the aorta and vena cava proximally at the diaphragm and distally above the femoral bifurcation. The system was flushed of blood with 20 ml of lactated Ringer's solution. The portal vein was then cannulated with distal clamping at the porta hepatis so that isolated intestinal perfusion could be achieved with the aorta as the inlet and the portal vein as the outlet. Following a 90 minute ischemic time, perfusates containing modified hemoglobin (5 g/dl) and 4-hydroxybenzoate (5 mM) were infused at 0.8 ml/min for 10 min. Portal vein effluent samples were collected at 2.5 minute intervals. Hydroxyl radical generation was assessed by an aromatic hydroxylation technique with 4-hydroxybenzoate (4HB). Reaction of hydroxyl radical with 4HB produces 3,4 dihydroxybenzoate (3,4 DHBA). In the PolyHb group, the levels of 3,4-DHBA increased 10.75-13.58 x-fold above pre-perfusion values compared to 2.25-3.75 x-fold in PolyHb-SOD-CAT group. This indicates that PolyHb-SOD-CAT is effective in reducing in vivo hydroxyl radical generation following reperfusion. Since free radicals may play a major role in the pathogenesis of ischemia-reperfusion injury, this suggests a role for PolyHb-SOD-CAT as a possible protective perfusate in intestinal reperfusion injury.
Subject(s)
Catalase/pharmacology , Hemoglobins/pharmacology , Intestines/blood supply , Reperfusion Injury/drug therapy , Superoxide Dismutase/pharmacology , Animals , Anticarcinogenic Agents/analysis , Anticarcinogenic Agents/metabolism , Blood Substitutes/chemistry , Blood Substitutes/pharmacology , Catalase/chemistry , Cross-Linking Reagents/chemistry , Cross-Linking Reagents/pharmacology , Disease Models, Animal , Free Radicals/metabolism , Hemoglobins/chemistry , Hydroxybenzoates/analysis , Hydroxybenzoates/metabolism , Intestinal Mucosa/metabolism , Intestines/drug effects , Male , Parabens/analysis , Parabens/metabolism , Perfusion , Rats , Rats, Sprague-Dawley , Reperfusion Injury/metabolism , Superoxide Dismutase/chemistryABSTRACT
In this study, we prepared PolyHb-SOD-catalase (intermolecularly cross-linked hemoglobin, superoxide dismutase (SOD), and catalase). We found that PolyHb-SOD-catalase is effective in scavenging oxygen-derived free radicals. In the xanthine/xanthine oxidase system, the initial rate of cytochrome c reduction was 2.13 +/- 0.26 nmoles cyt. c/min for PolyHb alone. PolyHb- SOD-catalase reduced this to 0.56 +/- 0.08 nmoles cyt. c/min because of its ability to eliminate superoxide (O2-). Addition of PolyHb to 200 microM of hydrogen peroxide (H2O2), changed the H2O2 level slightly to 192 +/- 0.4 microM. Addition of PolyHb-SOD-catalase, on the other hand, lower the level to 41 +/- 0.3 microM. Results also show that both effects were dependent on the concentration of SOD-catalase cross-linked with hemoglobin. Oxidative challenge with H2O2 resulted in minimal changes in the absorbance spectra of PolyHb-SOD-catalase. With PolyHb, there were spectral changes reflecting the formation of methemoglobin and heme degradation. Furthermore, the amount of iron released, after incubation with 250 microM H2O2, was 6.8 +/- 1.8 micrograms/dl for PolyHb-SOD-catalase and 76.6 +/- 1.0 micrograms/dl for PolyHb. These results show that cross-linked SOD-catalase prevents oxidative reactions involving the hemoglobin component of PolyHb-SOD-catalase.